R. Neubig

BRAF Inhibitor Resistance Confers Increased Sensitivity to Mitotic Inhibitors

R. Neubig, Jens C. Schmidt, K. Gallo, 2021, bioRxiv.

Rho-mediated signaling promotes BRAF inhibitor resistance in de-differentiated melanoma cells

R. Lo, K. Gallo, T. Dexheimer, 2019, Oncogene.

Ibrutinib Blocks YAP1 Activation and Reverses BRAF Inhibitor Resistance in Melanoma Cells

Patrick A. Newbury, R. Neubig, A. Doseff, 2020, Molecular Pharmacology.

Rho-mediated gene transcription promotes BRAF inhibitor resistance in de-differentiated melanoma cells

K. Gallo, S. Misek, T. Dexheimer, 2018, bioRxiv.

Regulator of G‐Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for l‐Dopa‐induced dyskinesia

G. O’Keeffe, M. Morari, S. Fasano, 2021, British journal of pharmacology.